Aziagma 500mg 3 Tablets

Babies: Not applicable. Lactating mother: Aziagma tablet is safe to use in breastfeeding.
Human studies have shown that this drug not may pass into breast milk and does not harm the baby. But is a chance of causing diarrhoea or rash in the baby.
Pregnancy: Aziagma tablet is safe to use in pregnancy. Animal studies have suggested that this drug may not have harmful effects on developing babies.
Alcohol: It is not safe to consume alcohol with an aziagma tablet. Driving: It is safe to drive after taking this medication.
Kidney: Aziagma tablets must be used with caution in patients with kidney disease. Dose adjustment is required.
Consult your doctor. Liver: Aziagma tablet must be used with caution in patients with liver disease.
Dose adjustment is required. Consult your doctor..

Nausea Vomiting Abdominal pain Diarrhea.

Aziagma is an antibiotic (macrolide). It works by blocking the protein synthesis, which is required for bacteria to perform their important functions.
Hence, it stops the growth of bacteria. .

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Aziagma is used in the treatment of bacterial infections • It can be taken 1 hour before or 2 hours after food • Consult your doctor if you experienced allergic reactions like an itchy rash, swelling of the face, throat, or tongue, or breathing difficulties while taking this medication • Consult your doctor if notice blood in stools • Antacids should be taken before 3 hours or after taking aziagma.

Contraindications: • Aziagma + Bepridil: Concurrent use may result in an increased risk of qt- interval prolongation • Aziagma + Cisapride: Concurrent use may result in an increased risk of qt- interval prolongation • Aziagma + Ergotamine: Concurrent use may result in an increased risk of acute ergotism (nausea, vomiting, vasospastic ischemia) • Aziagma + Terfenadine: Concurrent use may result in an increased risk of qt- interval prolongation Major: • Aziagma + Acecainide: Concurrent use may result in an increased risk of cardiotoxicity • Aziagma + Amiodarone: Concurrent use may result in an increased risk of cardiotoxicity • Aziagma + Ceritinib: Concurrent use may result in an increased risk of qt-interval prolongation • Aziagma + Ciprofloxacin: Concurrent use may result in an increased risk of qt interval prolongation.